iberin has been researched along with paclitaxel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, TT; Guo, Q; He, XH; Li, X; Lin, B; Liu, FH; Wu, QJ; Zhang, TN | 1 |
1 other study(ies) available for iberin and paclitaxel
| Article | Year |
|---|---|
Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Isothiocyanates; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Reactive Oxygen Species; Tumor Burden | 2021 |